Helitaanka Himilooyinka Daaweynta
"U diyaargarow in lagu bartilmaameedsado" waa mabda'a ama habka lagu guuleystay ee daaweynta cudurrada iyo xaaladaha qaarkood. Istaraatijiyadii hore ayaa loo isticmaalay in lagu daaweeyo dhiig-karka, kolestaroolka sare, iyo sonkorowga. Hase yeeshee, xajmigaasi wuu ballaadhiyay oo loola dhaqmey si loo bartilmaameedsado ayaa ka dhigay fekerka farsamoyaqaanada cudurrada rheumatiska .
Isticmaalka istaraatijiyadda lagu beegsanayo waa inuu lahaadaa saddexdan arrimood
- bartilmaameed
- hab loo cabbiro haddii bartilmaameedka la dhufto ama lagu guuleysto
- fursadaha daaweynta ee suurtogalka ah oo suurtogal u ah in lagu weeraro bartilmaameedka
Marka la eego hypertension, akhriska cadaadiska dhiigga ee la beegsan yahay wuxuu ka yar yahay 150/100 mm Hg, iyada oo in ka yar 140/90 ay xitaa aad waxtar u leedahay yaraynta dhacdooyinka wadnaha. Si loo gaaro himilooyinka la rabo ee wadarta guud ee kolestaroolka iyo LDL, waxaa badanaa la ogolyahay dhuunta. Bukaanka qaba sonkorowga, waxaa jira tilmaamo daaweyneed oo loogu talagalay sonkorta dhiigga iyo hemoglobin A1C. Maxaa loo arkaa bartilmaameedka rheumatoloji?
Ku daawee Xogta Xanuunka Arthritis
Xanuunka arthritis-ka ee rheumatoid-ka , bartilmaameedka ugu muhiimsan waa furfurnaanta . Hawlgallada caafimaad ee hooseeya ayaa sidoo kale ah bartilmaameed kale, laga yaabee xitaa in badan oo la gaari karo oo run ahaantii ah xaalado badan. Si loola beegsado bartilmaameedka, bararka waa in la xakameeyaa ama la xakameeyo. Tani waxaa lagu qiyaasaa qiimeynta waxqabadka cudurka. DAS28 (Dhibcaha Waxqabadka Cudurada) ama CDAI (Tusmada Hawlgabka Cudurrada Clinic) ayaa ka mid ah hababka cudurka loo qiimeeyo.
Xilliga ugu badan ee korjoogteynta dhaqdhaqaaqa hawleedka lama go'aamiyo, laakiin DAS28 wax ka yar 2.6 ayaa guud ahaan loo tixgelinayaa inay muujinayso xasaasiyad ku jirta bukaanka rheumatoid arthritis.
Xiritaan kale oo muhiim ah oo aan la iska indha tirin - bartilmaameedyada daaweynta waa inay noqotaa mid shakhsi ahaaneed. Dhibaatooyinka , taariikhda munaasabadaha daroogada xun, iyo isugeyntooda ayaa la saameeyaa waa in la tixgeliyaa marka la samaynayo istaraatijiyad lagu beegsanayo.
Ku daawee Target in Lupus
Hawlwadeen caalami ah ayaa soo saarey daaweyn loogu talagalay istiraatijiyadda lupus sidoo kale. Ciidanku waxay aasaaseen xayiraad muujinaysa muuqaalka xubnaha, iyo sidoo kale calaamadaha nidaamka lupus, waa bartilmaameedka ugu muhiimsan ee daaweynta lupus. Daaweeyn kale oo lagu beegsanayo goolka loo yaqaan 'lupus' waxaa ka mid ah ka hortagga cambaarta , oo ay ku jiraan nephritis , calaamadaha neur socodka, iyo calaamadaha guud ee lupus. Ka-hortagga dhaawaca ayaa sidoo kale loo asaasay bartilmaameed, iyada oo ujeedadeedu tahay in looga hortago dhaawaca xubinta taranka iyo soo-daahidda iyadoo la xakameynayo waxqabadka cudurrada iyo sunta ee daawooyinka. Fikradda la siiyay tayada bukaanka ayaa sidoo kale muhiim ah.
Hawlaha horay u sii socoshada, xoogagga hawlgalku waxay doonayaan in ay soo saaraan qeexitaan ku saabsan isdhaafidda lupus iyo waxqabadka cudurka ee la aqbali karo. Waxa kale oo jira baahi loo qabo qiimeyn wanaagsan oo cirka isku shareeraya.
Inkastoo ay rajo ka qabaan daawooyinka cusub ee lupus mustaqbalka, waxaa jiray dad badan oo horumarineed oo laga iibsaday rheumatoid arthritis taniyo 1998 (markii Enbrel uu noqday daroogada ugu horeysa ee loo yaqaan 'biologic drug for rheumatoid arthritis'). Marka laga hadlayo daawooyinka hadda loo isticmaalo daaweynta lupus, guddi-howleedku wuxuu raadin doonaa in uu go'aamiyo haddii ay jirto heer hoose oo steroids ah oo loo tixgelinayo in ay tahay mid ammaan ah oo lagu daaweynayo istaraatijiyad lagu beegsanayo.
Sidoo kale, su'aallo ku saabsan habboonaanta daaweynta hydroxychloroquine ee dhammaan bukaannada lupus weli jira.
Ku daawee Targeting for Spondyloarthritis
Sannadkii 2013, guddi khabiir ah ayaa la tixgeliyay in bukaanada qaba spondyloarthritis ay ka faa'iideysan karaan daaweyn si ay u bartilmaameed u noqoto. Waxay ku soo gabagaboobeen in daaweynta loogu talagalay la beegsan karo oo loo yaqaan 'spondyloarthritis' laakiin ujeedada tilmaamaysa sida loo qeexo, loo cabbiro ama xitaa lagu gaaro ujeedooyinka furfurista ama cudurrada aan firfircooneyn ayaa hoos udhaca qaybta cudurkan. Dembiyada weli wali ma jiraan kuwaas oo tilmaamaya tallaabooyinka qiyaasida ee waxqabadka cudurka ee spondyloarthritis. Shaqadu waxay u baahan tahay in la qabto. Hadda, talooyinka waxaa lagu sameeyey caddayn aan toos ahayn.
Mid ka mid ah daraasaddan, gaar ahaan cudurka psoriasis arthritis , ayaa la barbar dhigtay koox bukaan ah oo qaata daryeelka caadiga ah ee daawada methotrexate ee koox kale kuwaas oo heley daryeel dheeraad ah oo daroogada ah. Sida laga soo xigtay Rheumatology News, kooxda kacdoonku waxay raaceen qawaaniin adag iyo haddii shuruudaha firfircoonaanta cudurrada ay ku fashilmeen, markaa qiyaasta daawada methotrexate ayaa kor u kacday. Mar labaad, haddii ay bukaanku ku guuldareysteen in uu la kulmo shuruudaha waxqabadka cudurka, waxaa la siiyey isku-dhaf adag oo DMON ah . Haddii aysan wali gaarin bartilmaameedka, kooxda sii xoogeysan waxaa la siiyay TNF Blocker . Natiijooyinka waxay muujiyeen in kooxda xoogga leh ay ka fiicnaadeen kooxda heerka joogtada ah ee ku jiray daawada methotrexate iyada oo aan qorshe loogu talagelin kicinta daroogada ama cabbiraadda waxqabadka cudurka.
Sidoo kale, shir sannadeedka Yurub ee Rheumatology (EULAR 2014), muddo 5 sano ah oo lagu kordhiyey tijaabada la xakameeyey ee Simponi (golimumab) ee bukaanka qaba cudurka "psoriatic arthritis" waxay muujisay natiijada ka soo baxda mudada dheer ee bukaannada si ay u gaarsiiyaan waxqabadka cudurka daaweyn si loola beegsado.
Khadadka hoose
Cilmi baadhayaashu waxay sameeyeen baadhitaan habaysan oo suugaaneed oo cilmi ah (Schoels, M. et al.) Iyada oo la tixraacayo daaweyn si loo beegsado rheumatoloji. Waxay ku soo gabagaboobey in "daraasado yar oo kaliya ay adeegsadeen qaab la kala soocay si loo tijaabiyo qiimaha daaweynta si loo gaaro bartilmaameed gaar ah, si kastaba ha ahaatee, dhammaantood waxay bixiyeen caddaymo ku filan oo ku saabsan faa'iidooyinka daaweynta ee habka caynkaas ah Si kastaba ha ahaatee, xog badan ayaa loo baahan yahay oo ku saabsan natiijooyinka shucaaca iyo natiijooyinka hawlgalka iyo bukaannada qaba RA-da [rheumatoid arthritis-ka] oo aan muddo dheer la baarin. "
Arin ahaan, ujeedooyin daaweyn gaar ah, gaar ahaan ujeedooyinka daaweynta la gaari karo, waxay macno u leedahay. Si taas loo dhigo, bartilmaameedyada ama hadafyada waa in ay noqdaan kuwo si fiican u qeexaya cudurrada rheumatiska.
> Ilo:
> 'U diyaari bartilmaameedka': Ujeedooyinka laga guurayo ka yimaada hypertension, Hyperlipidaemia iyo Sonkorowga Rheumatoid Arthritis. Dan Atar et al. Annals of Cudurada Rheumatic . Abriil 2010.
> Caddaynta Daaweynta Rheumatoid Xanuunka Arthritis-ka ee Bartilmaameedka: Natiijooyinka Raadinta Sayniska ee nidaamsan. Schoels M. et al. Annals of Cudurada Rheumatic . Abriil 2010.
> Daaweeyn Si Ujeeddo Lupus Erythematosus: Talo-soo-jeedin ka timid Ciidanka Xoogga ee Caalamiga ah. Van Vollenhoven RF et al. Annals of Cudurada Rheumatic . Loo daabacay shabakadda internetka April 16, 2014.
> Daaweynta Spondyloarthritis, oo ay ku jirto Ankylosing Spondylitis iyo Arthritis-ka, si loogu beegsado: Talo soo jeedin ah oo ku saabsan Ciidanka Xoogga Caalamiga ah. Smolen JS et al. Annals of Cudurada Rheumatic . Juun 8, 2013.
> Ujeeddo-ula-Socosho U jeedka Xanuunka Cudurka Psoriatic Found useful. Rheumatology News . Doug Brunk. Nofeembar 4, 2013.
> Daaweeynta Target waxay muujinaysaa Hagaajin joogto ah ee Arthritis. War Saxaafadeedka gudaha . Jennie Smith. Juun 12, 2014.